Annual CFI
$64.39 M
+$232.40 M+138.32%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual cash flow from investing activities is $64.39 million, with the most recent change of +$232.40 million (+138.32%) on December 31, 2023.
- During the last 3 years, NMRA annual CFI has risen by +$75.62 million (+672.99%).
- NMRA annual CFI is now at all-time high.
Performance
NMRA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$156.99 M
+$135.73 M+638.59%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly cash flow from investing activities is $156.99 million, with the most recent change of +$135.73 million (+638.59%) on September 30, 2024.
- Over the past year, NMRA quarterly CFI has increased by +$306.99 million (+204.66%).
- NMRA quarterly CFI is now at all-time high.
Performance
NMRA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$41.92 M
+$133.17 M+145.94%
September 30, 2024
Summary
- As of February 7, 2025, NMRA TTM cash flow from investing activities is $41.92 million, with the most recent change of +$133.17 million (+145.94%) on September 30, 2024.
- Over the past year, NMRA TTM CFI has increased by +$130.35 million (+147.40%).
- NMRA TTM CFI is now -34.90% below its all-time high of $64.39 million, reached on December 31, 2023.
Performance
NMRA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NMRA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +138.3% | +204.7% | +147.4% |
| 3 y3 years | +673.0% | +272.4% | +123.6% |
| 5 y5 years | - | +272.4% | +123.6% |
NMRA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +138.3% | at high | +204.7% | -34.9% | +123.6% |
| 5 y | 5-year | at high | +138.3% | at high | +204.7% | -34.9% | +123.6% |
| alltime | all time | at high | +138.3% | at high | +204.7% | -34.9% | +123.6% |
Neumora Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $156.99 M(+638.6%) | $41.92 M(-145.9%) |
| Jun 2024 | - | $21.25 M(-114.2%) | -$91.25 M(+3.2%) |
| Mar 2024 | - | -$150.00 M(-1196.7%) | -$88.43 M(-237.3%) |
| Dec 2023 | $64.39 M(-138.3%) | $13.68 M(-42.6%) | $64.39 M(+50.9%) |
| Sep 2023 | - | $23.82 M(-1.1%) | $42.68 M(+20.0%) |
| Jun 2023 | - | $24.08 M(+754.7%) | $35.56 M(-144.7%) |
| Mar 2023 | - | $2.82 M(-135.1%) | -$79.59 M(-52.6%) |
| Dec 2022 | -$168.01 M | -$8.03 M(-148.1%) | -$168.01 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $16.69 M(-118.3%) | -$160.17 M(-9.7%) |
| Jun 2022 | - | -$91.07 M(+6.4%) | -$177.41 M(+105.2%) |
| Mar 2022 | - | -$85.61 M(>+9900.0%) | -$86.45 M(>+9900.0%) |
| Dec 2021 | -$817.00 K(-92.7%) | - | - |
| Dec 2021 | - | -$188.00 K(-65.6%) | -$817.00 K(+29.9%) |
| Sep 2021 | - | -$547.00 K(+401.8%) | -$629.00 K(+667.1%) |
| Jun 2021 | - | -$109.00 K(-503.7%) | -$82.00 K(-403.7%) |
| Mar 2021 | - | $27.00 K | $27.00 K |
| Dec 2020 | -$11.24 M | - | - |
FAQ
- What is Neumora Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Neumora Therapeutics?
- What is Neumora Therapeutics annual CFI year-on-year change?
- What is Neumora Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly CFI year-on-year change?
- What is Neumora Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Neumora Therapeutics?
- What is Neumora Therapeutics TTM CFI year-on-year change?
What is Neumora Therapeutics annual cash flow from investing activities?
The current annual CFI of NMRA is $64.39 M
What is the all time high annual CFI for Neumora Therapeutics?
Neumora Therapeutics all-time high annual cash flow from investing activities is $64.39 M
What is Neumora Therapeutics annual CFI year-on-year change?
Over the past year, NMRA annual cash flow from investing activities has changed by +$232.40 M (+138.32%)
What is Neumora Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of NMRA is $156.99 M
What is the all time high quarterly CFI for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly cash flow from investing activities is $156.99 M
What is Neumora Therapeutics quarterly CFI year-on-year change?
Over the past year, NMRA quarterly cash flow from investing activities has changed by +$306.99 M (+204.66%)
What is Neumora Therapeutics TTM cash flow from investing activities?
The current TTM CFI of NMRA is $41.92 M
What is the all time high TTM CFI for Neumora Therapeutics?
Neumora Therapeutics all-time high TTM cash flow from investing activities is $64.39 M
What is Neumora Therapeutics TTM CFI year-on-year change?
Over the past year, NMRA TTM cash flow from investing activities has changed by +$130.35 M (+147.40%)